Single Center, Open-label, Dose-increasing Phase I Clinical Trial of UC-MSCs for the Treatment of Knee Osteoarthritis
Latest Information Update: 15 Jul 2024
At a glance
- Drugs Umbilical cord mesenchymal stem cell therapy Wuhan Hamilton Biotechnology (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
Most Recent Events
- 01 Jul 2024 Planned End Date changed from 20 Sep 2025 to 30 Oct 2026.
- 01 Jul 2024 Planned primary completion date changed from 5 Jul 2024 to 30 Oct 2024.
- 01 Jul 2024 Planned initiation date changed from 28 Jun 2024 to 30 Jun 2024.